Expression and clinical implication of PRL-1 and PRL-3 in transitional cell carcinoma of bladder

Abstract

The mRNA and protein expression of phosphatase of regenerating liver 1 (PRL-1) and phosphatase of regenerating liver 3 (PRL-3) in transitional cell carcinoma of bladder (BTCC) and normal epithelia of bladder was investigated, and the relationship between the BTCC and pathological changes was clarified. The expression of PRL-1 and PRL-3 mRNA was detected by using reverse transcription polymerase chain reaction (RT-PCR) in 30 cases of BTCC and 10 cases of normal bladder, and the expression of PRL-1 and PRL-3 protein was checked by using immunohistochemistry in 30 cases of BTCC and 15 cases of normal bladder. The expression levels of PRL-1 and PRL-3 mRNA and protein were higher in BTCC than those in normal bladder epithelia (P<0.05). The increased expression of PRL-1 and PRL-3 mRNA and protein was detectable in deep invasion and metastasis of BTCC (P<0.05). There was no correlation between the expression of PRL-1 and PRL-3 and gender, age or recurrence of BTCC (all P>0.05). A significantly positive correlation was found between PRL-1 and PRL-3 in BTCC (P<0.05). PRL-1 and PRL-3 are expressed consistently and may contribute to the growth, differentiation, invasion and metastasis of BTCC.

Keywords

transitional cell carcinoma of bladder / phosphatase of regenerating liver 1 / phosphatase of regenerating liver 3 / reverse transcription polymerase chain reaction / immunohistochemistry

References

[1] HunterT. Signaling — 2000 and beyond. Cell, 2000, 100(1): 113-127

[2] LyonM A,DucruetA P,WipfP,LazoJ S. Dual-specificity phosphatases as targets for antineoplastic agents. Nat Rev Drug Discov, 2002, 1(12): 961-976

[3] ZengQ,SiX,HorstmannH,XuY,HongW,PallenC J. Prenylation dependent association of protein-tyrosine phosphatases PRL-1, -2, and-3 with the plasma membrane and the early endosome. J Biol Chem, 2000, 275(28): 21444-21452

[4] DiamondR H,CressmanD E,LazT M,AbramsC S,TaubR. PRL-1, a unique nuclear protein tyrosine phosphatase, affects cell growth. Mol Cell Biol, 1994, 14(6): 3752-3762

[5] ZengQ,DongJ M,GuoK,LiJ,KohV,PallenC J,ManserE,HongW. PRL-3 and PRL-1 promote cell migration, invasion, and metastasis. Cancer Res, 2003, 63(11): 2716-2722

[6] WangQ,HolmesD I,PowellS M,LuQ L,WaxmanJ. Analysis of stromal-epithelial interactions in prostate cancer identifies PTPCAAX2 as a potential oncogene. Cancer Lett, 2002, 175(1): 63-69

[7] SahaS,BardelliA,BuckhaultsP,VelculescuV E,RagoC,St CroixB,RomansK E,ChotiM A,LengauerC,KinzlerK W,VogelsteinB. A phosphatase associated with metastasis of colorectal cancer. Science, 2001, 294(5545): 1343-1346

[8] MiskadU A,SembaS,KatoH,YokozakiH. Expression of PRL-3 phosphatase in human gastric carcinomas: close correlation with invasion and metastasis. Pathobiology, 2004, 71(4): 176-184

[9] RadkeI,GötteM,KerstingC,MattssonB,KieselL,WülfingP. Expression and prognostic impact of the protein tyrosine phophatases PRL-1, PRL-2 and PRL-3 in breast cancer. Brit J Cancer, 2006, 95(3): 347-354

[10] ZhangZ Y,ZhouB,XieL. Modulation of protein kinase signaling by protein phosphatases and inhibitor. Pharmacol Ther, 2002, 93(2,3): 307-317

[11] DumaualC M,SanduskyG E,CrowellP L,RandallS K. Cellular localization of PRL-1 and PRL-2 gene expression in normal adult human tissues. J Histochem Cytochem, 2006, 54(12): 1401-1412

[12] MatterW F,EstridgeT,ZhangC,BelagajeR,StancatoL,DixonJ,JohnsonB,BloemL,PickardT,DonaqhueM,ActonS,JeyaseelanR,KadambiV,VlahosC J. Role of PRL-3, a human muscle-specific tyrosine phosphatase, in angiotensin-II signaling. Biochem Biophys Res Commun, 2001, 283(5): 1061-1068

[13] CatesC A,MichaelR L,StayrookK R,HarveyK A,BurkeY D,RandallS K,CrowellP L,CrowellD N. Prenylation of oncogenic human PTP (CAAX) protein tyrosine phosphatases. Cancer Lett, 1996, 110(1,2): 49-55

[14] MiskadU A,SembaS,KatoH,MatsukawaY,KodamaY,MizuuchiE,MaedaN,YanagiharaK,YokozakiH. High PRL-3 expression in human gastric cancer is a marker of metastasis and grades of malignancies: an in situ hybridization study. Virchows Arch. 2007, 450(3): 303-310

[15] PolatoF,CodegoniA,FruscioR,PeregoP,ManqioniC,SahaS,BardelliA,BroqqiniM. PRL-3 phosphatase is implicated in ovarian cancer growth. Clin Cancer Res, 2005, 11(9 Pt 1): 6835-6839

[16] WuX,ZengH,ZhangX,ZhaoY,ShaH,GeX,ZhangM,GaoX,XuQ. Phosphatase of regenerating liver-3 promotes motility and metastasis of mouse melanoma cells. Am J Pathol, 2004, 164(6): 2039-2054

[17] PengL,NingJ,MengL,ShouC. The association of the expression level of protein tyrosine phosphatase PRL-3 protein with liver metastasis and prognosis of patients with colorectal cancer. J Cancer Res Clin Oncol, 2004, 130(9): 521-526

[18] BardelliA,SahaS,SagerJ A,RomansK E,XinB,MarkowitzS D,LengauerC,VelculescuV E,KinzlerK W,VoqelsteinB. PRL-3 expression in metastatic cancers. Clin Cancer Res, 2003, 9(15): 5607-5615

[19] GuoK,LiJ,TangJ P,KohV,GanB Q,ZengQ. Catalytic domain of PRL-3 plays an essential role in tumor metastasis: formation of PRL-3 tumors inside the blood vessels. Cancer Biol Ther, 2004, 3(10): 945-951

[20] SagerJ,BenvenutiS,BardelliA. PRL-3: a phosphatase for metastasis?Cancer Biol Ther, 2004, 3(10): 952-953

RIGHTS & PERMISSIONS

2014 Higher Education Press and Springer-Verlag Berlin Heidelberg